Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat

胃癌细胞对EGF受体抑制剂的获得性易感性是由I类组蛋白去乙酰化酶抑制剂恩替诺特（entinostat）引起的。